Avanos Medical Inc (AVNS)

SG&A Expenses

$71.20M

Quarterly · Period ending: · USD

AVNS logo

AVNS SG&A Expenses

Latest reported$71.20M
AVNS Quarterly SG&A Expenses ($92.50M → $71.20M)
High-resolution chart · PNG

AVNS sg&a expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Avanos Medical Inc SG&A Expenses — Quarterly (USD)
Period endingSG&A Expenses (USD)
71,200,000
77,700,000
62,200,000
79,000,000
77,100,000
81,100,000
69,000,000
73,200,000
80,400,000
66,000,000
63,900,000
79,200,000
78,400,000
78,300,000
78,100,000
82,200,000
85,700,000
71,000,000
71,900,000
68,300,000
73,100,000
51,700,000
75,400,000
61,600,000
75,500,000
95,900,000
80,700,000
70,000,000
76,300,000
74,700,000
80,400,000
75,800,000
83,500,000
75,400,000
76,400,000
79,400,000
98,200,000
110,100,000
89,300,000
107,900,000
92,800,000
98,300,000
97,200,000
105,800,000
97,200,000
126,400,000
111,300,000
101,300,000
85,500,000
84,500,000
82,500,000
91,900,000
92,500,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.